Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy

Fig. 2

The Kaplan–Meier analysis of RFS and OS for patients based on MLR, tumor number, and tumor size. a is the Kaplan–Meier analysis of RFS; b is the Kaplan–Meier analysis of OS. RFS: recurrence-free survival; OS: overall survival; MLR: the monocyte to lymphocyte ratio. t.n: tumor number; t.s: tumor size

Back to article page